EP0920286A1 - Endoluminaler stent - Google Patents

Endoluminaler stent

Info

Publication number
EP0920286A1
EP0920286A1 EP97932958A EP97932958A EP0920286A1 EP 0920286 A1 EP0920286 A1 EP 0920286A1 EP 97932958 A EP97932958 A EP 97932958A EP 97932958 A EP97932958 A EP 97932958A EP 0920286 A1 EP0920286 A1 EP 0920286A1
Authority
EP
European Patent Office
Prior art keywords
stent
network
gold
wire
metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97932958A
Other languages
English (en)
French (fr)
Inventor
Laszlo Major
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0920286A1 publication Critical patent/EP0920286A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00395Coating or prosthesis-covering structure made of metals or of alloys
    • A61F2310/00419Other metals
    • A61F2310/00568Coating made of gold or Au-based alloys

Definitions

  • the present invention relates to endoluminal stent with tubular network stucture to eliminate the narrowing of blood vessels or other luminal passage ways of the human body, which stent disposed in the expanded location of the said lumen can stabilise the expanded diameter of it.
  • the known endoluminal grafts or stents are used mainly to treat narrowing of blood vessels. It can be a network structure of metal wire or can be made of metal tube with slots by laser. These products are different by the metal-component and the design of the network.
  • One of the well-known products is the slotted tube stent design of Johnson & Johnson Co, which has less diameter in elongated state, thus it is easy to dispose in the desired location of the lumen, wherein the rhomboidal structure opens and the stent will be shorter, simultaneously its diameter bigger.
  • Some stent types are crimped on a balloon catheter, and in the lumen the stent will be enlarged with help blowing of the balloon, which just after will be removed from the blood vessel.
  • stent are made of the special tissuefil and metalworking metal ,,316L Stainless Steel" produced for this purpose and keeps its network shape and size against the pressure of the lumen's wall. Further it is known and used other stents made of resilient material being unstable and tense at elongated state, therefore they dispose it closed in the lumen with help of a protection casing. After removing the said casing the self-expandable stent opens and steps in stabile state.
  • the shape of Medtronic stent's network is a plurality of loops on both directions on a virtual cylindrical surface.
  • the wire helix of Cordis stent includes a main helix line and a second one on it, quasi ..modulated" the main line by the second one.
  • Cobalt- steel gives the resilient property to the structure.
  • stents made of plastic material, and it is known the use of tantalum-alloy too.
  • the Schneider Co produces a stent wherein the network lays between an inner and an outer coaxial catheter, just removing them after the stent is disposed in the desired location.
  • the AVE Advanced- ced Vascular Engineering. uses multiple units defined as endless zig-zag line wire cylinders with welded joints one to other.
  • the first object of present invention is to develop an endoluminal stent for stabilising the enlarged state of blood vessel or other endoluminal passageway producing with a quality according to medical requires in lower cost than the known products even in small series production.
  • a further purpose of the present invention is to eliminate the drawbacks of the known products said in prior art, especially the bad X-ray contrast.
  • the inventiv step based the present invention is the idea that we may eliminate the dangerous wire-ends and the linkages between the segments applying endless wire filament merely with one welding point on the conjoin of two end of said filament. It was recognized that may prove the satisfactory radial force against the wall-pres- sure of blood vessel with help spot welding on a few cross of filament.
  • the invention is endoluminal stent with tubular network structure to eliminate the narrowing of blood vessels or other luminal passageways of the human body, which stent disposed in the expanded location of the said lumen to stabilize the expanded diameter of it, and in the state disposed in desired location of the blood vessel or the other luminal passageway of the human body the radial force of it is greater than the recoil of the blood vessel, and may characterized by that the network structure of the stent is made by an endless self contained monofilament of metal-wire.
  • the said stent especially may characterized by that the 50-100% of the nodel cross of the network the crossing wire filaments are fixed one to other, preferably with help of spot welding. Also especially the said stent is made of noble metal or it is coated with precious metal.
  • the longitudinal size of the network in our stent preferably may characterized by the general formula [ n.k + j ] . L wherein theticianL" is the length of one lead in the helix for any wire filament in the network, the ,,n" is an integral number especially between 5 and 24, the value ,,k" is 0,125, the value réellej" may be 0,06-0,13, so these means that the length of stent is about any multiple of the one eighth of theticianL".
  • An other object is of this invention a stent to eliminate the narrowing of blood vessel or other endoluminal passageway of human body which may characterized in that the stent is made of noble metal, especially of gold, or is coated with precious metal, f.e. with gold.
  • the invention will be demonstrated detail with help of the drawings but without limiting the claims to the examples of demonstration. Figures
  • Figure 1 A view of an preferred embodiment of the stent according to the present invention.
  • Figure 2. The theoretical schema of the structure of the stent according Fig.1.
  • the stent 10 includes the wire 2 starting from the lower and upper loops 4 being accordingly the Fig.1. on the left end of the stent 10 and running along a virtual cylinder surface. Both left loop 4 is the start-point of an right-, and an left helix-line which more times cross 3 one the other on the said cylinder surface and finally its unite in the two loops 4 found before an behind on the right end of stent 10.
  • the 50% of the nodel cross 3 of the network 1 the crossing wire filaments 2 are fixed one to the other with help of spot welding.
  • the wire 2 composes thus the network 1 on the virtual cylinder surface forming an endless self-contained curveline.
  • the said example is a network 1 having two loops 4 on its each end.
  • the network openings may be at most 2,3 mm, what means a network 1 with at least four loops 4 on both ends further the network 1 is formed by four left-helix and four right- helix wires 2, but all the said wires 2 together create one monofilament. It is used embodiment with five, six or eight loops 4 both end of the network 1.
  • the wire 2 is made of the commercial 316L stainless steel or of with treated reinforced gold or of gold coated wire-metal.
  • the proposed diameter of the stent 10 for coronary blood vessel is 3-5 mm made of about 0,2 mm diameter wire 2, for peripheral blood vessels 3-12 mm diameter of stent with about 0,3 mm diameter wire 2.
  • the stent diameter must be 10-15 mm and the wire diameter 0,3-0,4 mm, further it is proposed for swalling throat (i.e. gullet) 28 mm stent diameter with about 0,5 mm wire diameter.
  • the stent must supplied at least eight-eight wire 2, except the coronary disease for what is enough four-four left and right helix line to create the network 1.
  • Using precious metal may apply also the silver or the gold-silver alloy instead of with crystalline treat reinforced gold.
  • the lead angle of network 1 may be 45°-60° concerning to the end plane of the structure's virtual cylinder.
  • the length of the stent 10 is the summerized length of the united networks 1. The length of the network 1 is a function of the lead but against it we may define it in a wide range.
  • the length of the network 1 must be an integral multiple of the suboctuple lead [,,L"] because the three-dimen- sionai monofilament network may best form on this way.
  • the ,,L" length we can reasonable accept as period-length because inside of this length all wire-segments, starting whether to left or right direction from the loops 4, make a whole spiral-lead.
  • our network 1 is 8 mm long in enlarged state and 10 mm long in elongated state.
  • the 20 mm long enlarging balloon we achieve the stent- length accordingly the 20 mm long enlarging balloon and this stent 10 is very flexible consequently its two part construction against it length.
  • the network 1 has a length characterized with the formula : 0,125 n L + j.L wherein the provoken" is a simple integral preferably in the scale 4 -12, the valve of ,,j" is in the range 0.06-0,13. Clearly about a suboctuple length-extension is necessary for the back-turning the filament i.e.
  • the stent according to present invention is cheaper than the laser slotted network structure and may be produced economically also in smaller series. Compared to the known stents with network structure of wire the products of present invention has no free wire ending and despite it comprises only one welding for that. A number of reinforcing welding may be used additionally.
  • the stent of present invention shows controllable X-ray visibility in the group of known stent, because of the amount and ratio of the noble metal used.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Prostheses (AREA)
EP97932958A 1996-07-31 1997-07-28 Endoluminaler stent Withdrawn EP0920286A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9602099A HU217501B (hu) 1996-07-31 1996-07-31 Endoluminális tágítóbetét
HU9602099 1996-07-31
PCT/HU1997/000042 WO1998004211A1 (en) 1996-07-31 1997-07-28 Endoluminal stent

Publications (1)

Publication Number Publication Date
EP0920286A1 true EP0920286A1 (de) 1999-06-09

Family

ID=89994172

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97932958A Withdrawn EP0920286A1 (de) 1996-07-31 1997-07-28 Endoluminaler stent

Country Status (4)

Country Link
EP (1) EP0920286A1 (de)
AU (1) AU3631697A (de)
HU (1) HU217501B (de)
WO (1) WO1998004211A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8623067B2 (en) 2004-05-25 2014-01-07 Covidien Lp Methods and apparatus for luminal stenting
SG175723A1 (en) 2004-05-25 2011-12-29 Tyco Healthcare Vascular stenting for aneurysms
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
WO2005115118A2 (en) 2004-05-25 2005-12-08 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
EP1883371B1 (de) 2005-05-25 2015-10-07 Covidien LP System und verfahren zur abgabe und ablage und zum verschluss einer vorrichtung in einem gefäss
WO2007100556A1 (en) 2006-02-22 2007-09-07 Ev3 Inc. Embolic protection systems having radiopaque filter mesh
US9114001B2 (en) 2012-10-30 2015-08-25 Covidien Lp Systems for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
USD898136S1 (en) 2018-08-27 2020-10-06 Coulter Ventures, Llc. Implement for exercise rack

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1205743A (en) * 1966-07-15 1970-09-16 Nat Res Dev Surgical dilator
US5102417A (en) 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4969458A (en) * 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
CA1322628C (en) 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US5161547A (en) * 1990-11-28 1992-11-10 Numed, Inc. Method of forming an intravascular radially expandable stent
US5354308A (en) * 1992-05-01 1994-10-11 Beth Israel Hospital Association Metal wire stent
ES2102722T3 (es) * 1994-04-26 1997-08-01 Ruesch Willy Ag Dilatador auto-expandible de organos huecos.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9804211A1 *

Also Published As

Publication number Publication date
HUP9602099A1 (hu) 1998-08-28
HU9602099D0 (en) 1996-09-30
HU217501B (hu) 2000-02-28
AU3631697A (en) 1998-02-20
WO1998004211A1 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
US20010000043A1 (en) Flexible expandable stent
US20010018595A1 (en) Flexible expandable stent
CA2195783C (en) A flexible expandable stent
US7763068B2 (en) Stent
EP2425800B1 (de) Implantierbare intraluminale Vorrichtung und Verfahren zu ihrer Verwendung bei der Behandlung von Aneurysmen
EP0947180A3 (de) Stent Aneurismus-Behandlungssystem und Einführverfahren
US5860999A (en) Stent and method of using same
US5503636A (en) Self-expanding stent for hollow organs
EP1570807A2 (de) Intraluminarer Stent zur Anwendung in Körpergefässen mit variablem Durchmesser
KR20010035531A (ko) 세로로 유연한 스텐트
WO1999044537A1 (en) A corrugated stent
EP1087729A1 (de) Selbstexpandierende, sich verzweigende, endovaskulare prothese
EP0920286A1 (de) Endoluminaler stent
KR100241822B1 (ko) 내강 확장용 스텐트
AU779582B2 (en) A stent
AU2004203556B2 (en) A Stent
AU3124699A (en) A stent
HK1077188A (en) Braided tubular implant

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990122

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

17Q First examination report despatched

Effective date: 20010122

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020201